Stock analysts at StockNews.com began coverage on shares of Avinger (NASDAQ:AVGR – Get Free Report) in a research note issued on Wednesday. The firm set a “hold” rating on the medical device company’s stock.
Avinger Price Performance
Shares of AVGR stock opened at $0.55 on Wednesday. The business has a fifty day moving average of $0.75 and a 200 day moving average of $0.97. Avinger has a 1 year low of $0.39 and a 1 year high of $5.45. The firm has a market capitalization of $1.82 million, a price-to-earnings ratio of -0.05 and a beta of 1.15.
Avinger (NASDAQ:AVGR – Get Free Report) last released its earnings results on Thursday, November 7th. The medical device company reported ($1.82) EPS for the quarter, topping analysts’ consensus estimates of ($2.03) by $0.21. Avinger had a negative return on equity of 5,527.11% and a negative net margin of 261.06%. The firm had revenue of $1.65 million during the quarter, compared to the consensus estimate of $1.60 million. During the same quarter in the previous year, the company posted ($2.92) earnings per share. As a group, equities research analysts expect that Avinger will post -4.69 earnings per share for the current year.
About Avinger
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Further Reading
- Five stocks we like better than Avinger
- 3 Warren Buffett Stocks to Buy Now
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- How to Short a Stock in 5 Easy Steps
- What Does the Future Hold for Eli Lilly?
- 3 Warren Buffett Stocks to Buy Now
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.